Abstract | OBJECTIVE: METHODS: Forty seven-day-old Sprague-Dawley rats were randomly divided into normal control (N), HI, UCBMC and HI+UCBMC groups (n=10 each). Hypoxic-ischemic brain damage (HIBD) model was prepared according to the Rice method. Twenty-four hours after hypoxia, the N and HI groups were injected with 2 μL phosphate buffered saline (PBS), and the UCBMC and HI+UCBMC groups were injected with 3×10(6) UCBMC via the lateral ventricle. EPO protein and oligodendrocyte progenitor cells in the subventricular zone of the injured brain were observed by EPO/ DAPI and NG2/ DAPI immunofluorescence double staining, and their correlation was analyzed. RESULTS: Seven days after transplantation, there were more NG2(+) DAPI(+) and EPO(+) DAPI(+) cells in the HI+UCBMC group than in the UCBMC (P<0.05), N and HI groups (P<0.01). More NG2(+) DAPI(+) and EPO(+) DAPI(+) cells were observed in the UCBMC group compared with the N and HI groups (P<0.01). There were more NG2(+) DAPI(+) cells in the N group than in the HI group (P<0.01). The number of NG2(+) DAPI(+) cells was correlated with the number of EPO(+) DAPI(+) cells in the HI+UCBMC group (r=0.898, β=1.4604, P<0.01). CONCLUSIONS: UCBMC can promote expression of oligodendrocyte progenitor cells, which is correlated with an increase in EPO protein and thus repairs brain white matter damage in neonatal rats with HIBD.
|
Authors | Jia-Fen Ji, Jin-Ping Zhang, Xiao-Li Wang, Qing-Jie Mu, Meng-Meng Fan, Yu-Xi Chen |
Journal | Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
(Zhongguo Dang Dai Er Ke Za Zhi)
Vol. 15
Issue 9
Pg. 775-8
(Sep 2013)
ISSN: 1008-8830 [Print] China |
PMID | 24034924
(Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Animals
- Animals, Newborn
- Erythropoietin
(analysis, biosynthesis)
- Fetal Blood
(cytology)
- Hypoxia-Ischemia, Brain
(metabolism, pathology, therapy)
- Monocytes
(transplantation)
- Oligodendroglia
(pathology)
- Rats
- Rats, Sprague-Dawley
- Stem Cells
(pathology)
|